Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
ID: 350176Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $100K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350176

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-300.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Global Infectious Disease Research Administration Development Award, aimed at enhancing the grants management capabilities of research institutions in low- and middle-income countries (LMICs). This funding opportunity seeks to provide senior administrators from these institutions with advanced training in managing NIH grants, focusing on improving compliance and oversight of NIAID grant awards. The initiative is crucial for strengthening research infrastructure in LMICs, fostering collaborations between U.S. and foreign research organizations, and advancing global health initiatives. Eligible applicants can receive awards of up to $100,000 per year for a project period not exceeding two years, with applications due by March 13, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-300-Full-Announcement.html
    PAR-23-300.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is inviting applications for the Global Infectious Disease Research Administration Development Award aimed at enhancing grants management capabilities for research institutions in low- and middle-income countries (LMICs). The initiative seeks to provide senior administrators from these institutions with advanced training in managing NIH grants, specifically focusing on improving compliance and oversight of NIAID grant awards. The funding opportunity allows for awards up to $100,000 per year, with a project period not to exceed two years. Key components of the application include a Research Grants Administration Plan, Staff Training Plan, and a Long-Term Plan, supplemented by letters of support from both the LMIC and U.S. institutions involved. The program encourages institutions to adopt best practices in grants management, enhance operational efficiency, and foster an environment conducive to research activities. This opportunity reflects the NIH's commitment to strengthening research infrastructure in LMICs to advance global health initiatives and enhance collaborations between U.S. and foreign research organizations. Applications must be submitted electronically, adhering to specific timelines and application requirements outlined in the notice of funding opportunity.
    Similar Opportunities
    Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Global Infectious Disease Research Training Program (D43 Clinical Trial Optional), aimed at enhancing research capacity in low- and middle-income countries (LMICs) regarding infectious diseases. This program encourages collaborative applications from U.S. and LMIC institutions, focusing on critical areas such as neglected tropical diseases and co-infections in HIV patients, while excluding HIV/AIDS as a primary focus. Successful applicants will develop structured training curricula, mentorship pairings, and research skills relevant to local health priorities, with annual budgets capped at $230,000 for a maximum project period of five years. Interested parties should note that the application deadline is August 6, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)" aimed at supporting research on infectious diseases in resource-constrained countries. This initiative encourages applications from organizations based in low- and lower-middle-income economies, as classified by the World Bank, and seeks innovative proposals addressing diseases such as HIV/AIDS, tuberculosis, and malaria, with a focus on enhancing local scientific capacity. The total funding available for fiscal year 2024 is approximately $1,360,000, with individual project budgets capped at $125,000 per year for a maximum of five years. Interested applicants can find more information and submission guidelines at the NIH website, with applications accepted until August 1, 2025.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity through the Small Research Grant Program (R03) aimed at supporting junior faculty researchers in low- and middle-income countries (LMICs) who are focused on aging, Alzheimer's Disease (AD), and AD-related dementias (ADRD). This initiative encourages applications from eligible institutions within LMICs, with the objective of fostering research capacity and career development for junior investigators in these regions. Given the projected increase in older populations and the rising incidence of AD/ADRD in LMICs, this program is critical for addressing global health challenges. Interested applicants can apply for grants of up to $100,000 per year, with a submission deadline of February 14, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the International Research Scientist Development Award (IRSDA) (K01), a federal grant aimed at supporting advanced postdoctoral U.S. research scientists and recently-appointed junior faculty in developing their careers in global health. Applicants are required to propose research projects that address health priorities in low- and middle-income countries (LMIC) while being mentored by both U.S. and LMIC-based mentors, committing at least 75% of their professional effort to the research. This program emphasizes the importance of fostering collaborative global health partnerships and aims to build a diverse global health workforce, providing up to $100,000 annually in salary and $40,000 for research development costs. Interested applicants must submit their proposals by March 9, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.
    International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the International Research Scientist Development Award (IRSDA), a federal grant aimed at supporting advanced postdoctoral researchers and junior faculty from the U.S. in their career development through mentored research experiences in low- and middle-income countries (LMICs). Applicants must be at least two years post-doctorate and are required to propose research projects that align with the health priorities of the selected LMIC, working under the guidance of both U.S. and LMIC mentors. The award provides up to $100,000 annually for the recipient's salary and $40,000 for research-related expenses, with a funding period of three to five years. Interested applicants must submit their proposals by March 9, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-114.html.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)" to stimulate research aligned with the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative aims to support research on HIV-related comorbidities, gastrointestinal diseases, and metabolic disorders associated with HIV, encouraging applications from a diverse range of organizations, including higher education institutions and non-profits. With an estimated funding of $2 million for fiscal year 2025, the NIH plans to support 3 to 5 selected projects over a maximum project period of five years, with applications undergoing a rigorous peer review process. Interested applicants can find more information and submit their proposals through Grants.gov, with a submission deadline of January 7, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries," aimed at fostering collaborative research on Alzheimer's disease (AD) and related dementias (ADRD) in low- and middle-income countries (LMICs). This initiative seeks to build sustainable neuroscience research capacity by encouraging partnerships between U.S. researchers and scientists from LMICs, focusing on population-relevant studies that address the unique epidemiological and risk factors associated with AD/ADRD in diverse populations. The program will provide a total of $2.16 million for up to five awards, with individual application budgets capped at $400,000 annually over a five-year period. Interested applicants must submit their proposals by February 14, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the STrengthening Research Opportunities for NIH Grants (STRONG) program, which focuses on conducting structured institutional needs assessments and developing action plans for Resource Limited Institutions (RLIs). The initiative aims to enhance the research capacity of RLIs, which serve historically underrepresented populations in biomedical research and have received NIH support of $0 to $25 million annually over the past three fiscal years. This program is crucial for improving competitiveness for NIH funding and fostering research career development in diverse environments. Eligible institutions can apply for a maximum budget of $250,000 annually for a project period of three years, with applications due by September 18, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.